IL6 and non-small cell lung carcinoma: Using quantitative ELISA, we showed that secreted IL-6 in the gMSI2 CAF-CM was substantially lower than that in the Ctrl CAF-CM (Fig. 4C), thus supporting IL-6 as a prime candidate in CAF regulation of NSCLC progression.